| Brand Name | Ositab |
| Packaging Type | Bottle |
| Molecule | Osimertinib |
| Generic Name | Osimertinib 80mg |
| Manufactured By | Azista |
| Quantity | 30 tablets in 1 bottle |
| Form | Tablets |
| Country of Origin | Bhutan |
| Categories | Oncology |
Intoduction to Ositab Osimertinib 80mg Tablets
Ositab 80mg contain Osimertinib, a powerful third-generation tyrosine kinase inhibitor (TKI). Formulated for treating non-small cell lung cancer (NSCLC) that has mutations in the epidermal growth factor receptor (EGFR). This targeted therapy functions by blocking the activity of abnormal proteins that facilitate the growth and multiplication of cancer cells. By blocking these protein cells, Ositab 80mg can help slow down cancer progression and may contribute to reducing tumor size.
Indication: Ositab 80mg is recommended for patients with EGFR-mutated NSCLC, especially those who have experienced disease progression following previous treatment with EGFR TKIs. It serves as a therapeutic option for advanced or metastatic lung cancer, offering hope to patients who have developed resistance to previous treatments
Key Benefits:
- Specifically targets EGFR mutations in NSCLC.
- Helps slow cancer progression by inhibiting abnormal proteins.
- Potentially reduces tumor size.
- Suitable for patients who have progressed on prior EGFR-TKI therapy.
- Ositab 80mg offers a targeted and advanced solution for managing EGFR-mutated NSCLC, providing a critical option for patients who have progressed after prior treatments.
Ositab 80mg Dosage
The recommended dose is 80 mg once daily, with or without food. Ositab should be taken as prescribed by a patient’s healthcare specialist, and regular monitoring is important to ensure maximum treatment response.
Ositab 80mg Precautions:
- Ositab should be used under the guidance of a healthcare provider.
- Inform the patient's doctor of any underlying medical conditions, such as lung or heart problems.
- Avoid taking the Ositab Osimertinib 80mg Tablets with certain foods or other drugs that may interfere with its effectiveness.
